The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Severino Michael since 2017.
This trader's CIK number is 1609447.
At the time of last reporting, Severino Michael was the Vice Chairman of Abbvie Inc.. (stock ticker symbol ABBV).
Also see all insider trading activities at Abbvie Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | ABBV | 0 | $0 | 579,801 | $88,339,117 | 579,801 | $41,155,625 |
| 2020 | ABBV | 0 | $0 | 90,679 | $8,488,461 | 0 | $0 |
| 2018 | ABBV | 0 | $0 | 52,643 | $5,183,783 | 0 | $0 |
| 2017 | ABBV | 0 | $0 | 25,633 | $2,427,214 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-05-23 | ABBV | Option Ex | 79,801 | 104.59 | 8,346,625 |
| 2022-05-23 | ABBV | Sale | 79,801 | 151.16 | 12,062,719 |
| 2022-05-16 | ABBV | Option Ex | 100,000 | 70.19 | 7,019,000 |
| 2022-05-17 | ABBV | Option Ex | 100,000 | 86.26 | 8,626,000 |
| 2022-05-16 | ABBV | Sale | 100,000 | 154.76 | 15,476,000 |
| 2022-05-17 | ABBV | Sale | 100,000 | 154.40 | 15,439,700 |
| 2022-05-09 | ABBV | Option Ex | 100,000 | 56.87 | 5,687,000 |
| 2022-05-10 | ABBV | Option Ex | 100,000 | 60.12 | 6,012,000 |
| 2022-05-09 | ABBV | Sale | 100,000 | 150.53 | 15,052,699 |
| 2022-05-10 | ABBV | Sale | 100,000 | 152.08 | 15,207,700 |
| 2022-05-06 | ABBV | Option Ex | 100,000 | 54.65 | 5,465,000 |
| 2022-05-06 | ABBV | Sale | 100,000 | 151.00 | 15,100,299 |
| 2020-11-04 | ABBV | Sale | 90,679 | 93.61 | 8,488,461 |
| 2018-08-17 | ABBV | Sale | 50,000 | 97.44 | 4,872,100 |
| 2018-02-28 | ABBV | Sale | 2,643 | 117.93 | 311,683 |
| 2017-11-10 | ABBV | Sale | 25,633 | 94.69 | 2,427,214 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Severino Michael (Vice Chairman of Abbvie Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.